Description
DEOBLIGATE FUNDING - RADIOPHARMACEUTICALS | TASK ORDER
Base award description: RADIOPHARMACEUTICALS | TASK ORDER
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-03-22+$43,145= $43,145
- Mod P000012026-05-15-$20,231= $22,914
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-03-22 | +$43,145 | $43,145 | RADIOPHARMACEUTICALS | TASK ORDER |
| Mod P00001· FUNDING ONLY ACTION | 2026-05-15 | −$20,231 | $22,914 | DEOBLIGATE FUNDING - RADIOPHARMACEUTICALS | TASK ORDER |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI LM6RSRTLHTE6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24526N0078 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $70,190 | FY2026 |
| 36C24525N0077 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $60,624 | FY2025 |
| 36C24524D0027 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36C24224N0086 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $169,179 | FY2024 |
| 36C24223N0048 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $635,965 | FY2023 |
| 36C24222N0160 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $600,000 | FY2022 |
Other recipients under 6505 from 245-NETWORK CONTRACT OFFICE 5 (36C245) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24526N0840 | TAKEDA PHARMACEUTICALS AMERICA, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $19,139 | FY2026 |
| 36C24526N0839 | TAKEDA PHARMACEUTICALS AMERICA, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $38,360 | FY2026 |
| 36C24526N0837 | QOL MEDICAL LLC | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $16,945 | FY2026 |
| 36C24526N0835 | TAKEDA PHARMACEUTICALS AMERICA, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $34,605 | FY2026 |
| 36C24526N0834 | GALDERMA LABORATORIES, L.P. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $16,960 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24524F0346_3600_36C24524D0027_3600 · retrieved 2026-09-26.